LEXICON PHARMACEUTICALS, INC. (LXRX) Stock buybacks 2016–2024
LEXICON PHARMACEUTICALS, INC. (LXRX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$1.7MFY2024 · since FY2016: $621,000 → $1.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $1.7M | +110.0% |
| FY2023 | $824,000 | -4.6% |
| FY2022 | $864,000 | -67.7% |
| FY2021 | $2.7M | +160.7% |
| FY2020 | $1.0M | +9.0% |
| FY2019 | $941,000 | -3.2% |
| FY2018 | $972,000 | -42.1% |
| FY2017 | $1.7M | +170.4% |
| FY2016 | $621,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LXRX financial trends
LXRX RevenueLXRX Net incomeLXRX Net marginLXRX Gross profitLXRX Gross marginLXRX Operating incomeLXRX Operating marginLXRX Operating cash flowLXRX Free cash flowLXRX Capital expendituresLXRX Return on equityLXRX Dividends paidLXRX Total assetsLXRX Total liabilitiesLXRX Shareholders’ equityLXRX overview →